Enzyme inhibition in drug discovery and development : the good and the bad
著者
書誌事項
Enzyme inhibition in drug discovery and development : the good and the bad
Wiley, c2010
- : cloth
大学図書館所蔵 件 / 全4件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
"A John Wiley & Sons, Inc., publication"
Includes bibliographical references and index
収録内容
- The drug discovery process / Gerald T. Miwa
- Medicinal chemistry of the optimization of enzyme inhibitors / Geraldine Harriman, Amy Elder, and Indranath Ghosh
- Bioanalytical technologies in drug discovery / Jing-Tao Wu
- Safety biomarkers in drug development : emerging trends and implications / Eric R. Fedyk
- The role of drug metabolism in drug discovery / Tonika Bohnert and Liang-Shang Gan
- Applied pharmacokinetics in drug discovery and development / Hua Yang ... [et al.]
- Enzyme inhibition and inactivation : cytochrome P450 enzymes / R. Scott Obach
- Cytochrome P450 induction / Edward L. LeCluyse ... [et al.]
- Inhibition of drug-metabolizing enzymes in the gastrointestinal tract and its influence on the drug-drug interaction prediction / Aleksandra Galetin and J. Brian Houston
- Enzyme inhibition in various in vitro systems / Ping Zhao
- Cytochrome P450 Degradation and its clinical relevance / Mingxiang Liao ... [et al.]
- Complexities of working with UDP-Giucuronosyltransferases (UGTs) : focus on enzyme inhibition / Michael B. Fisher
- Evaluation of inhibitors of drug metabolism in human hepatocytes / Albert P. Li and Chuang Lu
- Grapefruit juice and its constituents as new esterase inhibitors / Suresh K. Balani
- Transporter-Xenobiotic Interactions : an important aspect of drug development studies / Gang Luo, Richard Ridgewell, and Thomas Guenthner
- Polymorphisms of drug transporters and their clinical implications / Cindy Q. Xia and Johnny J. Yang
- Clinical drug interactions due to metabolic inhibition : prediction, assessment, and interpretation / Lisa L. von Moltke and David J. Greenblatt
- Predicting interindividual variability of metabolic drug-drug interactions : identifying the causes and accounting for them using a systems approach / Amin Rostami-Hodjegan
- NF-KB : mechanism, tumor biology, and inhibitors / Lenny Dang
- G-Protein-Coupled receptors as drug targets / Wenyan Miao and Lijun Wu
- Pharmacological modulation of ion channels for the treatment of chronic pain / Yi Liu and Ning Qin
- Targeting the mTOR pathway for tumor therapeutics / Wei Chen
- HIV-1 protease inhibitors as antiretroviral agents / Selgei V. Gulnik, Elena Afonina, and Michael Eissenstat

